JP2003519102A5 - - Google Patents

Download PDF

Info

Publication number
JP2003519102A5
JP2003519102A5 JP2001541509A JP2001541509A JP2003519102A5 JP 2003519102 A5 JP2003519102 A5 JP 2003519102A5 JP 2001541509 A JP2001541509 A JP 2001541509A JP 2001541509 A JP2001541509 A JP 2001541509A JP 2003519102 A5 JP2003519102 A5 JP 2003519102A5
Authority
JP
Japan
Prior art keywords
compound
embedded image
pharmaceutical composition
treating
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001541509A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003519102A (ja
Filing date
Publication date
Priority claimed from US09/454,074 external-priority patent/US6878716B1/en
Priority claimed from US09/454,075 external-priority patent/US6686366B1/en
Application filed filed Critical
Priority claimed from PCT/US2000/032702 external-priority patent/WO2001039777A1/en
Publication of JP2003519102A publication Critical patent/JP2003519102A/ja
Publication of JP2003519102A5 publication Critical patent/JP2003519102A5/ja
Pending legal-status Critical Current

Links

JP2001541509A 1999-12-02 2000-12-01 アデノシンa▲下1▼、a▲下2a▼およびa▲下3▼受容体に対して特異的な化合物並びにその使用 Pending JP2003519102A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US45425499A 1999-12-02 1999-12-02
US09/454,074 1999-12-02
US09/454,074 US6878716B1 (en) 1998-06-02 1999-12-02 Compounds specific to adenosine A1 receptor and uses thereof
US09/454,075 US6686366B1 (en) 1998-06-02 1999-12-02 Compounds specific to adenosine A3 receptor and uses thereof
US09/454,075 1999-12-02
US09/454,254 1999-12-02
PCT/US2000/032702 WO2001039777A1 (en) 1999-12-02 2000-12-01 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof

Publications (2)

Publication Number Publication Date
JP2003519102A JP2003519102A (ja) 2003-06-17
JP2003519102A5 true JP2003519102A5 (cg-RX-API-DMAC7.html) 2009-04-09

Family

ID=27412585

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001541509A Pending JP2003519102A (ja) 1999-12-02 2000-12-01 アデノシンa▲下1▼、a▲下2a▼およびa▲下3▼受容体に対して特異的な化合物並びにその使用

Country Status (15)

Country Link
EP (2) EP1731520A1 (cg-RX-API-DMAC7.html)
JP (1) JP2003519102A (cg-RX-API-DMAC7.html)
KR (1) KR100840727B1 (cg-RX-API-DMAC7.html)
AT (1) ATE335489T1 (cg-RX-API-DMAC7.html)
AU (1) AU784878B2 (cg-RX-API-DMAC7.html)
CA (1) CA2393179A1 (cg-RX-API-DMAC7.html)
CY (1) CY1107653T1 (cg-RX-API-DMAC7.html)
DE (1) DE60030002T2 (cg-RX-API-DMAC7.html)
DK (1) DK1246623T3 (cg-RX-API-DMAC7.html)
ES (1) ES2269217T3 (cg-RX-API-DMAC7.html)
HK (1) HK1050319B (cg-RX-API-DMAC7.html)
IL (2) IL149935A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA02005357A (cg-RX-API-DMAC7.html)
PT (1) PT1246623E (cg-RX-API-DMAC7.html)
WO (1) WO2001039777A1 (cg-RX-API-DMAC7.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0103836A3 (en) 1998-06-02 2003-05-28 Osi Pharmaceuticals Inc Uniond Pyrrolo[2,3d]pyrimidine compositions and their use
US6660731B2 (en) 2000-09-15 2003-12-09 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US7473691B2 (en) 2000-09-15 2009-01-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
AU2001290912A1 (en) 2000-09-15 2002-03-26 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US6680324B2 (en) 2000-12-01 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
UA74228C2 (uk) * 2000-12-01 2005-11-15 Осі Фармасьютікалз, Інк. ПОХІДНІ ПІРОЛО[2,3-d]ПІРИМІДИНУ, СПЕЦИФІЧНІ ДО АДЕНОЗИНОВОГО A<sub>1</sub>, A<sub>2А</sub> І A<sub>3</sub> РЕЦЕПТОРА, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ
BR0115847A (pt) * 2000-12-01 2004-02-25 Osi Pharm Inc Compostos especìficos para receptor para adenosina a1, a2a, e a3 e usos dos mesmos
BR0116493A (pt) 2000-12-21 2003-09-30 Vertex Pharma Compostos de pirazol úteis como inibidores de proteìna cinase
UA80258C2 (en) * 2001-09-06 2007-09-10 Biogen Inc Methods of treating pulmonary disease
DE10148883A1 (de) * 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
JP2005529062A (ja) 2001-11-30 2005-09-29 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド アデノシンa1及びa3受容体に特異的な化合物とその使用
JP2005516917A (ja) 2001-12-12 2005-06-09 アメリカ合衆国 細胞外アデノシン阻害剤およびアデノシン受容体阻害剤を用いて免疫応答および炎症を増強するための方法
KR20040068317A (ko) 2001-12-20 2004-07-30 오에스아이 파마슈티컬스, 인코포레이티드 피리미딘 a₂b 선택성 길항 화합물, 그의 합성 방법 및용도
EA012926B1 (ru) * 2001-12-20 2010-02-26 Оси Фармасьютикалз, Инк. Пирролопиримидиновые соединения, относящиеся к a-селективным антагонистам, их синтез и применение
DE60236458D1 (de) 2001-12-20 2010-07-01 Osi Pharm Inc Pyrrolopyrimidin a2b selektive antagonistische verbindungen, deren synthese und verwendung
CA2479036A1 (en) 2002-03-13 2003-09-18 Euro-Celtique S.A. Aryl substituted pyrimidines and the use thereof
MY141867A (en) 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
MXPA05001367A (es) 2002-08-02 2005-04-28 Vertex Pharma Composiciones de pirazol utiles como inhibidores de gsk-3.
JP4895806B2 (ja) * 2003-04-09 2012-03-14 エクセリクシス, インク. Tie−2モジュレータと使用方法
AR043880A1 (es) * 2003-04-22 2005-08-17 Solvay Pharm Gmbh Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas
WO2005004875A1 (ja) * 2003-07-14 2005-01-20 Sankyo Company, Limited 経肺投与用医薬組成物
JP5249770B2 (ja) 2005-11-03 2013-07-31 バーテックス ファーマシューティカルズ インコーポレイテッド キナーゼインヒビターとして有用なアミノピリジン
CN101443344B (zh) 2006-03-27 2012-08-29 大塚化学株式会社 海藻糖化合物及含有该化合物的药物
US20100273776A1 (en) * 2006-03-29 2010-10-28 FOLDRx PHARMACEUTICALS, INC Inhibition of alpha-synuclein toxicity
TW200808819A (en) * 2006-06-19 2008-02-16 Solvay Pharm Gmbh Use of adenosine A1 antagonists in radiocontrast media induced nephrophaty
KR20100016270A (ko) * 2007-05-11 2010-02-12 산텐 세이야꾸 가부시키가이샤 비맥각계의 선택적 d2 수용체 작용제를 유효 성분으로서 함유하는 후안부 질환의 예방 또는 치료제
WO2009052376A1 (en) 2007-10-18 2009-04-23 Musc Foundation For Research Development Methods for the diagnosis of genitourinary cancer
AR070127A1 (es) 2008-01-11 2010-03-17 Novartis Ag Pirrolo - pirimidinas y pirrolo -piridinas
PL2651417T3 (pl) 2010-12-16 2017-08-31 Calchan Limited Pochodne pirolopirymidyny hamujące ASK1
BR112014030416A2 (pt) * 2012-06-07 2017-06-27 Hoffmann La Roche composto, métodos para a inibição da tankyrase 1 e para o tratamento do câncer, utilização de um composto, composição e invenção.
GB201711234D0 (en) 2017-07-12 2017-08-23 Galapagos Nv Pyrrolopyrimidine and pyrrolopyridine derivatives
KR20240018000A (ko) * 2022-08-01 2024-02-13 주식회사 넥스트젠바이오사이언스 A3 아데노신 수용체 작용제로서의 신규한 퓨린 유도체 화합물
TW202509030A (zh) * 2023-05-08 2025-03-01 美商譚格醫療公司 化合物及使用方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910913A (en) * 1969-11-04 1975-10-07 American Home Prod 4,5-Diamino-7H-pyrrolo{8 2,3-d{9 pyrimidine derivatives
US5516894A (en) 1992-03-11 1996-05-14 The General Hospital Corporation A2b -adenosine receptors
PT633886E (pt) * 1992-04-03 2001-03-30 Upjohn Co Aminas biciclicas-heterociclicas farmaceuticamente activas
WO1995011681A1 (en) 1993-10-29 1995-05-04 Merck & Co., Inc. Human adenosine receptor antagonists
IT1277392B1 (it) 1995-07-28 1997-11-10 Schering Plough S P A Analoghi eterociclici di 1,2,4-triazolo(1,5-c]pirimidine ad attivita' antagonista per il recettore a2a dell'adenosina
US5780450A (en) 1995-11-21 1998-07-14 Alcon Laboratories, Inc. Use of adenosine uptake inhibitors for treating retinal or optic nerve head damage
WO1997033879A1 (en) 1996-03-15 1997-09-18 Merck & Co., Inc. Compounds and methods for selectively inhibiting activation of the human a3 adenosine receptor
JPH09291089A (ja) 1996-04-26 1997-11-11 Yamanouchi Pharmaceut Co Ltd 新規な5−チアゾリルウラシル誘導体又はその塩
US5786360A (en) 1996-11-19 1998-07-28 Link Technology Incorporated A1 adenosine receptor antagonists
CA2296485A1 (en) 1997-07-29 1999-02-11 Medco Research, Inc. N6-substituted-adenosine-5'-uronamides as adenosine receptor modulators
HUP0103836A3 (en) * 1998-06-02 2003-05-28 Osi Pharmaceuticals Inc Uniond Pyrrolo[2,3d]pyrimidine compositions and their use
US9816053B2 (en) 2015-03-26 2017-11-14 Melynda S DelCotto Candle having a wooden wick with figured grain

Similar Documents

Publication Publication Date Title
JP7688681B2 (ja) アルドース還元酵素阻害剤およびその使用方法
US10639306B2 (en) Aldose reductase inhibitors and uses thereof
AU2005215320B2 (en) Amino alcohol compound
CN103052637B (zh) 醛糖还原酶抑制剂及其用途
CA2855759C (en) Tricyclic compounds, compositions comprising them and uses thereof
CN105120866A (zh) 与毒性醛相关的疾病和治疗
JP2013056911A (ja) 運動障害の予防および/または治療剤
TW202019410A (zh) 作為用於治療神經退化性疾病的ppargc1a活化劑的2-芳基苯并咪唑
JP2009500409A (ja) 痛みを処置するためのα2アドレナリン作動剤
JPH01153689A (ja) 抗パーキンソン病エルゴリン誘導体
WO2016119570A1 (zh) 尿酸性或痛风性疾病的预防或治疗
JP2004517947A (ja) そう痒状態の処置のためのmglur5アンタゴニストの使用
JP2005511639A (ja) 虚血性疾患の治療用ドパミン再取り込み阻害活性を有するトロパン誘導体
US20260069585A1 (en) ISOQUINOLINE COMPOUNDS AND THEIR USE IN TREATING AhR MEDIATED DISEASES
JP2001524546A (ja) ベンゼンスルンアミド組成物
WO2008071869A2 (fr) Utilisation de l&#39;agomelatine pour le traitement de la leucomalacie periventriculaire
JPH0653678B2 (ja) アレルギ−性疾患治療剤
JP2023504547A (ja) アシル化された活性薬剤並びに代謝異常及び非アルコール性脂肪性肝疾患の治療のためのそれらの使用の方法
TWI293027B (cg-RX-API-DMAC7.html)
JP2025529076A (ja) AhR媒介疾患の治療に使用するタピナロおよびそのアナログ製剤
JP2023505233A (ja) アシル化された活性薬剤並びに代謝異常及び非アルコール性脂肪性肝疾患の治療のためのそれらの使用の方法
WO2005105147A2 (en) Combination of prostaglandin e2 receptor antagonists and renin-angiotensin system inhibitors for treating renal diseases
MXPA06009610A (en) Amino alcohol compound
HK1223925B (en) Aldose reductase inhibitors and uses thereof